Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 63(20): 11420-11435, 2020 10 22.
Article in English | MEDLINE | ID: mdl-32539387

ABSTRACT

Fragment-based drug discovery is a strategy widely used in both academia and pharmaceutical companies to generate small-molecule protein inhibitors and drug candidates. Among the approaches reported in the literature (growing, linking, and merging), the linking approach theoretically offers the opportunity to rapidly gain in binding energy. Nevertheless, this approach is poorly represented when considering the compounds currently in clinical trials. Here, we report an exhaustive view of the cases published so far in the literature, together with the methods used to identify the two initial fragments either simultaneously or successively. We review the different types of linkers published and discuss how these linkers are designed to obtain the lead compound. Mixing merging and linking methods, where the linker is duplicated from a known inhibitor, appears as an interesting strategy. To reach superadditivity, we propose to grow one of the fragments in order to minimize the distance between the two binders and then link the resulting compounds using flexible alkyl-derived linkers.


Subject(s)
Drug Design , Pharmaceutical Preparations/chemistry , Proteins/antagonists & inhibitors , Small Molecule Libraries , Binding Sites , Clinical Trials as Topic , Drug Approval , Ligands , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Protein Binding , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology , Structure-Activity Relationship
2.
Anal Chim Acta ; 1113: 26-35, 2020 May 29.
Article in English | MEDLINE | ID: mdl-32340666

ABSTRACT

Biophysical techniques that enable the screening and identification of weak affinity fragments against a target protein are at the heart of Fragment Based Drug Design approaches. In the case of membrane proteins, the crucial criteria for fragment screening are low protein consumption, unbiased conformational states and rapidity because of the difficulties in obtaining sufficient amounts of stable and functionally folded proteins. Here we show for the first time that lipid-nanodisc systems (membrane-mimicking environment) and miniaturized affinity chromatography can be combined to identify specific small molecule ligands that bind to an integral membrane protein. The approach was exemplified using the AA2AR GPCR. Home-made affinity nano-columns modified with nanodiscs-embedded AA2AR (only about 1 µg of protein per column) were fully characterized by frontal chromatographic experiments. This method allows (i) to distinguish specific and unspecific ligand/receptor interactions, (ii) to assess dissociation constants, (iii) to identify the binding pocket of uncharacterized ligands using a reference compound (whose binding site is known) with competition experiments. Weak affinity ligands with Kd in the low to high micromolar range can be detected. At last, the applicability of this method was demonstrated with 6 fragments recently identified as ligands or non-ligands of AA2AR.


Subject(s)
Immobilized Proteins/metabolism , Nanoparticles/chemistry , Organic Chemicals/analysis , Receptor, Adenosine A2A/metabolism , Chromatography, Affinity/methods , Drug Discovery , Humans , Immobilized Proteins/chemistry , Ligands , Membranes, Artificial , Organic Chemicals/metabolism , Proof of Concept Study , Protein Binding , Receptor, Adenosine A2A/chemistry
3.
Future Med Chem ; 11(14): 1811-1825, 2019 07.
Article in English | MEDLINE | ID: mdl-31287732

ABSTRACT

In this review, we report NMR studies of ligand-GPCR interactions, including both ligand-observed and protein-observed NMR experiments. Published studies exemplify how NMR can be used as a powerful tool to design novel GPCR ligands and investigate the ligand-induced conformational changes of GPCRs. The strength of NMR also lies in its capability to explore the diverse signaling pathways and probe the allosteric modulation of these highly dynamic receptors. By offering unique opportunities for the identification, structural and functional characterization of GPCR ligands, NMR will likely play a major role for the generation of novel molecules both as new tools for the understanding of the GPCR function and as therapeutic compounds for a large diversity of pathologies.


Subject(s)
Receptors, G-Protein-Coupled/chemistry , Humans , Ligands , Magnetic Resonance Spectroscopy , Receptors, G-Protein-Coupled/metabolism
4.
J Enzyme Inhib Med Chem ; 34(1): 1218-1225, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31286785

ABSTRACT

WaterLOGSY is a sensitive ligand-observed NMR experiment for detection of interaction between a ligand and a protein and is now well-established as a screening technique for fragment-based lead discovery. Here we develop and assess a protocol to derive ligand epitope mapping from WaterLOGSY data and demonstrate its general applicability in studies of fragment-sized ligands binding to six different proteins (glycogen phosphorylase, protein peroxiredoxin 5, Bcl-xL, Mcl-1, HSP90, and human serum albumin). We compare the WaterLOGSY results to those obtained from the more widely used saturation transfer difference experiments and to the 3D structures of the complexes when available. In addition, we evaluate the impact of ligand labile protons on the WaterLOGSY data. Our results demonstrate that the WaterLOGSY experiment can be used as an additional confirmation of the binding mode of a ligand to a protein.


Subject(s)
Drug Discovery/methods , Magnetic Resonance Spectroscopy/methods , Binding Sites , Proteins/chemistry
5.
Sci Rep ; 8(1): 8142, 2018 05 25.
Article in English | MEDLINE | ID: mdl-29802269

ABSTRACT

Structural studies of integral membrane proteins have been limited by the intrinsic conformational flexibility and the need to stabilize the proteins in solution. Stabilization by mutagenesis was very successful for structural biology of G protein-coupled receptors (GPCRs). However, it requires heavy protein engineering and may introduce structural deviations. Here we describe the use of specific calixarenes-based detergents for native GPCR stabilization. Wild type, full length human adenosine A2A receptor was used to exemplify the approach. We could stabilize native, glycosylated, non-aggregated and homogenous A2AR that maintained its ligand binding capacity. The benefit of the preparation for fragment screening, using the Saturation-Transfer Difference nuclear magnetic resonance (STD-NMR) experiment is reported. The binding of the agonist adenosine and the antagonist caffeine were observed and competition experiments with CGS-21680 and ZM241385 were performed, demonstrating the feasibility of the STD-based fragment screening on the native A2A receptor. Interestingly, adenosine was shown to bind a second binding site in the presence of the agonist CGS-21680 which corroborates published results obtained with molecular dynamics simulation. Fragment-like compounds identified using STD-NMR showed antagonistic effects on A2AR in the cAMP cellular assay. Taken together, our study shows that stabilization of native GPCRs represents an attractive approach for STD-based fragment screening and drug design.


Subject(s)
Drug Evaluation, Preclinical/methods , Magnetic Resonance Spectroscopy , Receptor, Adenosine A2A/chemistry , Receptor, Adenosine A2A/metabolism , Cyclic AMP/metabolism , Humans , Ligands , Models, Molecular , Protein Conformation , Protein Stability , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...